Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride adjunctive treatment for drug-resistant adult epilepsy
ChiCTR-ONC-13003234Phase 4Completed
- Sponsor
- Xijing Hospital
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amiloride in epilepsy, sponsored by Xijing Hospital. Primary endpoint: Seizure frequency. Started Jun 2013; status: completed.
02
Drugs
amiloride
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR-ONC-13003234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003234.